Dexcom, Abbott File Dueling Lawsuits On Diabetes Management Technology

07 Jul 2021

The two suits address a total of 17 patents on elements of continuous glucose monitors, or CGMs.

Dexcom's G6 devices are among the products under contention

Abbott and Dexcom, Inc. will face off in court over patents on technology used in continuous glucose monitor technology – a major growth area for both companies.

Medtech Strategy Must Be Priority, German Diagnostics Firms Tell Government

13 Apr 2025

• By Ashley Yeo

Germany’s incoming coalition government has reacted positively to industry’s calls for a dedicated medtech strategy to boost economic growth. Faster digitization, lower energy costs and “IVDR 2.0” are also on the in vitro diagnostic industry’s agenda.

FDA Reverses Course, Allows Some Telework For Reviewers

11 Apr 2025

• By Derrick Gingery

The new telework policy returns to the pre-COVID-19 pandemic standard, but still requires reviewers to be at White Oak for sponsor meetings and divisions to have an in-office presence every day.